Last updated on May 2019

Type 2 Diabetes (T2D) & Chronic Kidney Disease (CKD)

Brief description of study

A research study is evaluating the effects of Ozempic® (semaglutide), an FDA-approved antidiabetic medication, on renal impairment and cardiovascular conditions when added to current treatment for adults with type 2 diabetes.


Clinical Study Identifier: TX220960

Find a site near you

Start Over

PMG Research of Wilmington

1202 Medical Center Drive Wilmington, NC United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.